<DOC>
	<DOC>NCT00088049</DOC>
	<brief_summary>The purpose of the protocol is to evaluate the efficacy of olanzapine compared with Aripiprazole in patients with schizophrenia.</brief_summary>
	<brief_title>Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male or female inpatient or outpatients, ages 1865 Participation in a clinical trial of another drug including olanzapine or aripiprazole within 30 days prior to study entry (visit 1). Treatment with clozapine within the past 12 months. Have known uncorrected narrowangle glaucoma. Have a diagnosis of Parkinson's disease, dementia or related disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>